Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma
This study has been terminated.
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Collaborator:
Emergent Product Development Seattle LLC
Information provided by:
Wyeth is now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov Identifier:
NCT00521638
First received: August 24, 2007
Last updated: January 7, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2008 |
| Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | January 7, 2013 |